- Home
- GCTK vs PRSO Comparison
GCTK vs PRSO Comparison
Compare GCTK & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTK
- PRSO
- Stock Information
- Founded
- GCTK 2001
- PRSO 2008
- Country
- GCTK United States
- PRSO United States
- Employees
- GCTK N/A
- PRSO N/A
- Industry
- GCTK Medical/Dental Instruments
- PRSO Semiconductors
- Sector
- GCTK Health Care
- PRSO Technology
- Exchange
- GCTK Nasdaq
- PRSO Nasdaq
- Market Cap
- GCTK 4.1M
- PRSO 4.3M
- IPO Year
- GCTK N/A
- PRSO 2001
- Fundamental
- Price
- GCTK $6.59
- PRSO $1.09
- Analyst Decision
- GCTK
- PRSO Strong Buy
- Analyst Count
- GCTK 0
- PRSO 1
- Target Price
- GCTK N/A
- PRSO $3.00
- AVG Volume (30 Days)
- GCTK 1.6M
- PRSO 455.9K
- Earning Date
- GCTK 08-12-2025
- PRSO 08-11-2025
- Dividend Yield
- GCTK N/A
- PRSO N/A
- EPS Growth
- GCTK N/A
- PRSO N/A
- EPS
- GCTK N/A
- PRSO N/A
- Revenue
- GCTK N/A
- PRSO $15,626,000.00
- Revenue This Year
- GCTK N/A
- PRSO $3.96
- Revenue Next Year
- GCTK N/A
- PRSO $36.80
- P/E Ratio
- GCTK N/A
- PRSO N/A
- Revenue Growth
- GCTK N/A
- PRSO 35.50
- 52 Week Low
- GCTK $5.16
- PRSO $0.52
- 52 Week High
- GCTK $3,756.00
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- GCTK 35.94
- PRSO 56.63
- Support Level
- GCTK $5.94
- PRSO $1.03
- Resistance Level
- GCTK $15.90
- PRSO $1.31
- Average True Range (ATR)
- GCTK 1.57
- PRSO 0.15
- MACD
- GCTK -0.01
- PRSO -0.02
- Stochastic Oscillator
- GCTK 0.56
- PRSO 33.33
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.